GOLGA7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.327000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.975600E-01
Normal-vs-Stage2
2.486000E-01
Normal-vs-Stage3
1.518160E-01
Normal-vs-Stage4
3.297600E-01
Stage1-vs-Stage2
6.514800E-01
Stage1-vs-Stage3
4.429000E-01
Stage1-vs-Stage4
8.721600E-01
Stage2-vs-Stage3
5.199400E-01
Stage2-vs-Stage4
8.647400E-01
Stage3-vs-Stage4
4.990800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.145400E-01
Normal-vs-AfricanAmerican
2.194200E-01
Normal-vs-Asian
3.227400E-01
Caucasian-vs-AfricanAmerican
9.499800E-01
Caucasian-vs-Asian
9.635000E-01
AfricanAmerican-vs-Asian
9.833000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.438800E-01
Normal-vs-Female
2.297200E-01
Male-vs-Female
4.708200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.392400E-01
Normal-vs-Age(41-60Yrs)
3.603200E-01
Normal-vs-Age(61-80Yrs)
1.758180E-01
Normal-vs-Age(81-100Yrs)
1.795230E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.823400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.419200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.364000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.173500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.357600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.968400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.592170E-01
Normal-vs-Daily Drinker
4.503600E-02
Normal-vs-Weekly Drinker
2.357400E-01
Normal-vs-Occasional Drinker
2.607200E-01
Normal-vs-Social Drinker
3.329800E-01
Non Drinker-vs-Daily Drinker
4.708200E-01
Non Drinker-vs-Weekly Drinker
5.840000E-01
Non Drinker-vs-Occasional Drinker
4.755400E-01
Non Drinker-vs-Social Drinker
3.566200E-01
Daily Drinker-vs-Weekly Drinker
2.191200E-01
Daily Drinker-vs-Occasional Drinker
1.547050E-01
Daily Drinker-vs-Social Drinker
1.066580E-01
Weekly Drinker-vs-Occasional Drinker
9.138600E-01
Weekly Drinker-vs-Social Drinker
7.372400E-01
Occasional Drinker-vs-Social Drinker
8.064600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.529600E-01
Normal-vs-Grade 2
6.773600E-01
Normal-vs-Grade 3
6.503400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.963800E-01
Grade 1-vs-Grade 3
1.599560E-01
Grade 1-vs-Grade 4
4.529600E-01
Grade 2-vs-Grade 3
5.173000E-01
Grade 2-vs-Grade 4
6.773600E-01
Grade 3-vs-Grade 4
6.503400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.452220E-01
Normal-vs-NonDiabetic
1.996380E-01
Diabetic-vs-NonDiabetic
2.842800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.346200E-02
Normal-vs-NoPancreatitis
2.283800E-01
Pancreatitis-vs-NoPancreatitis
1.649040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.846630E-01
Normal-vs-N1
2.801400E-01
N0-vs-N1
3.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.169800E-01
Normal-vs-TP53-NonMutant
1.713620E-01
TP53-Mutant-vs-TP53-NonMutant
1.682790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
